Sign in
4

Changes in Ownership

LISATA THERAPEUTICS, INC. Filed Acc 0001879231-22-000002

EVP, R&D and CMO gave up 7,694 shares (to pay taxes)

  • EVP, R&D and CMO acquired 64,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Buck Kristen K · EVP, R&D and CMO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2022-01-10 Grant or award : show line 1 in the form +64,500 326,897 D
2022-01-10 Shares withheld for taxes : show line 2 in the form −7,694 $0.92 $7,055 319,203 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-01-10 Grant or award : show line 3 in the form Stock Option (Right to Buy) +32,500 32,500 D
Loading xslF345X03/wf-form4_164202231648913.xml…